# Feasibility and Usability of COVID-19 Antigen RDTs in Uganda

> **NCT05630300** · NA · COMPLETED · sponsor: **PATH** · enrollment: 1280 (actual)

## Conditions studied

- COVID-19 Pandemic

## Interventions

- **DIAGNOSTIC_TEST:** PMC Sure Status COVID-19 Antigen Test
- **DIAGNOSTIC_TEST:** Acon Flowflex COVID-19 Antigen Home Test

## Key facts

- **NCT ID:** NCT05630300
- **Lead sponsor:** PATH
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-01
- **Primary completion:** 2023-08-30
- **Final completion:** 2023-09-30
- **Target enrollment:** 1280 (ACTUAL)
- **Last updated:** 2023-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05630300

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05630300, "Feasibility and Usability of COVID-19 Antigen RDTs in Uganda". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05630300. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*